Brief: Xortx Completes Screening $ Enrollment In Bridging Pharmacokinetics Study
28/11/2022 12:32
Nov 28 (Reuters) - XORTX Therapeutics Inc XRTX.V :
* XORTX ANNOUNCES COMPLETION OF SCREENING AND ENROLLMENT IN
BRIDGING PHARMACOKINETICS STUDY
Source text for Eikon: ID:nGNX4kq0rz
Further company coverage: XRTX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Outlines Anticipated Health Canada Clinical Trial Application For Xrx-026 For Gout
Brief: XORTX Therapeutics Announces Initiation Of Drug And Tablet Manufacturing For XRx-026 Program
Brief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering